GEHC · PEAD ↑ 100

GE HealthCare reported Q3 2026 EPS of $1.34 on 2026-10-28, beating the $1.21 consensus by $0.13 (+10.7%).

Print-day reaction was +6.6% versus the prior close, a sharp gap-and-hold that carried the stock well above its pre-earnings range. The overnight gap from T+0 close to T+1 open added a further +0.5%, with no after-hours fade to speak of. Over the following two trading sessions the drift extended +4.1%, a steady continuation that showed no sign of mean-reversion. Cumulative abnormal return of +14.2% versus SPY — which itself fell 2.3% over the same window — places this firmly in PEAD long territory; the documented drift pattern holds through 2027-01-25.